NASDAQ:ADVM
Delisted

Advm Stock Predictions

etoro logo Buy ADVM
*Your capital is at risk
$4.36
+0 (+0%)
At Close: Mar 06, 2026
Currently predicting for Mon, 8 Jun 2026

ADVM Prediction Chart

ADVM Predictions History

Latest community submissions for ADVM.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 2, 2025 Bullish $5.27 V 1
Jul 31, 2023 $2.00 -90.36% $2.18 V 91.94% 0
Jul 31, 2023 $2.03 -90.23% $2.18 V 93.24% 0
Jul 31, 2023 Bullish $2.18 X 1
JS JS Pro
Jul 17, 2023 $1.95 -90.30% $2.23 V 87.44% 0
Jul 17, 2023 $1.95 -90.28% $2.23 V 87.61% 0
Jul 17, 2023 $1.97 -90.17% $2.23 V 88.56% 0
JS JS Pro
Jun 9, 2021 $3.61 -90.00% $3.61 X 100.00% 10
Jun 9, 2021 Bullish $3.61 X 1
JS JS Pro
May 3, 2021 $5.17 -86.10% $3.72 X 61.02% 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ADVM with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ADVM
ADVM
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal, including wet age-related macular degeneration and diabetic macular edema. Adverum Biotechnologies, Inc. has license and collaboration agreements with U...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
4.43% Jun 01
N
NVRI
$19.53
0.87% May 20
RUN
$12.83
15.51% May 06
GLBE
$31.61
4.05% May 05
SAP
$172.39
8.56% May 05

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE